Notice: Images are for illustration only and may not reflect the exact product you receive. Brand-name medications may look different depending on their country of origin—Canadian versions, for example, often include a "PR" symbol on the packaging. Rest assured, the medication, dosage, and active ingredients will be exactly as prescribed. Canada Pharmacy Store is committed to your health and safety, and we work only with licensed pharmacies to ensure you receive trusted, high-quality medication every time.
General Medication Fact Sheet for Rybelsus
| Field | Information |
|---|---|
| Medication Name | Rybelsus |
| Generic Name | Semaglutide |
| Purpose | To improve glycemic control in adults with type 2 diabetes mellitus, used along with diet and exercise. |
| Mechanism of Action | GLP-1 receptor agonist, enhances insulin secretion, suppresses glucagon secretion, and slows gastric emptying. |
| Dosage Forms | Oral tablets |
| Available Strengths | 3 mg, 7 mg, 14 mg |
| Dosage Frequency | Once daily |
| Common Side Effects | Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite. |
| Serious Side Effects | Pancreatitis, gallbladder problems, kidney problems, diabetic retinopathy complications, hypoglycemia (if used with other diabetes medications). |
| Drug Interactions | Insulin secretagogues (e.g., sulfonylureas), insulin, other oral medications (due to delayed gastric emptying). |
| Important Notes | Take on an empty stomach with a sip of water at least 30 minutes before the first food, beverage, or other oral medications of the day. Swallow whole; do not crush, chew, or cut. |
| Storage | Store at room temperature, away from moisture and light. |
| Missed Dose | Skip the missed dose and take your next dose at the regular time. Do not double the dose. |
| Alternatives | Ozempic (semaglutide injection), Trulicity (dulaglutide), Jardiance (empagliflozin), Metformin. |
Rybelsus Alternatives
| Medication | Mechanism of Action | Notes |
|---|---|---|
| Ozempic (semaglutide injection) | GLP-1 receptor agonist | Injectable form of semaglutide; similar mechanism to Rybelsus. |
| Trulicity (dulaglutide) | GLP-1 receptor agonist | Injectable GLP-1 RA, administered once weekly. |
| Jardiance (empagliflozin) | SGLT2 inhibitor | Works by preventing the kidneys from reabsorbing sugar, which is then excreted in urine. |
| Metformin | Biguanide; decreases glucose production in the liver and improves insulin sensitivity | First-line treatment for type 2 diabetes. |
Rybelsus Side Effects
| Common Side Effects | Serious Side Effects |
|---|---|
| Nausea | Pancreatitis |
| Vomiting | Gallbladder problems |
| Diarrhea | Kidney problems |
| Constipation | Diabetic retinopathy complications |
| Abdominal pain | Hypoglycemia (if used with other diabetes medications) |
| Decreased appetite | Allergic reactions (rash, itching, swelling, difficulty breathing) |
Rybelsus Dosage Guide
| Condition | Starting Dose | Maintenance Dose | Administration Notes |
|---|---|---|---|
| Type 2 Diabetes | 3 mg once daily for 30 days | 7 mg once daily (may increase to 14 mg once daily if needed after at least 30 days on the 7 mg dose) | Take on an empty stomach with a sip of water at least 30 minutes before the first food, beverage, or other oral medications of the day. |
Rybelsus Price With And Without Insurance
| Purchase Context | Estimated Price |
|---|---|
| With Insurance | $100 |
| Without Insurance (U.S.) | $1,100 |
| From CPS | $300 |



